19939 results for «»

Filter By

19939 results

EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency

04 Nov 2021

Elad Asher reviews the EROSION III trial, presented by Haibo Jia, which studied whether OCT guidance compared with angiographic guidance only is associated with lower stent rate implantation during pPCI in STEMI patients with non-obstructive stenosis.

Elad Asher

Author

Elad Asher
EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation

04 Nov 2021

Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...

Nicola Ryan

Author

Nicola Ryan
iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Discover how #PCRLV is fostering worldwide connections

This year’s Heart Team Course is boosting interaction for all participants, whether they join online or in person!
 Discover how #PCRLV is fostering worldwide connections

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

04 Nov 2021

TCT 2021: Luis Ortega Paz interviews Rafael Romaguera, principal investigator of the SUGAR trial. SUGAR is the first powered trial to compare new generation DES in patients with diabetes, and also the first to include a broad population of patients with diabetes (all-comers design). It was...

Luis Ortega-Paz

Author

Luis Ortega-Paz
Rafael Romaguera

Author

Rafael Romaguera
SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

TAVI in Asia-Pacific 2021: an update

08 Oct 2021 – From AICT-AsiaPCR 2021

Watch this session to be updated on the state of TAVI in 2021, especially in the Asia-Pacific Region, and learn more about the essential steps of TAVI procedure in a bicuspid valve.

TAVI in Asia-Pacific 2021: an update

Contemporary challenges in STEMI management

08 Oct 2021 – From AICT-AsiaPCR 2021

Watch this session on contemporary challenges in STEMI management to review the role for complete revascularisation in STEMI, to discuss challenges faced in managing STEMI in the COVID era, and to understand how to approach coronary calcification in STEMI.

Contemporary challenges in STEMI management

Treatment of aortic stenosis in patients with longer life expectancy: case-based heart team discussion

26 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session with a case-based heart team discussion to learn more about the treatment of aortic stenosis in patients with longer life expectancy: discover what the 2021 guidelines say about patient selection, what should be considered for patients with longer life expectancy, and how to optimise procedural outcome.

Treatment of aortic stenosis in patients with longer life expectancy: case-based heart team discussion

Case-based challenging TAVI

26 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session with challenging TAVI cases to learn more about indication and choice of treatment for patients with aortic stenosis, and discover some interesting tips and tricks to face tough situations. 

Case-based challenging TAVI

Bicuspid aortic valves: where do we stand?

26 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to learn more about bicuspid aortic valves: understand patient selection for TAVI, explore sizing and valve selection, and discover the key procedural steps for TAVI in bicuspid AV.

Bicuspid aortic valves: where do we stand?

Najmiddin Makhkamov

Tashkent, Uzbekistan

Wee Meng Ng

Singapore, Singapore

Bishnu Pada Saha

Dhaka, Bangladesh

Jonathan Ong

Singapore, Singapore

Kristy Garganera

Metro Manila, Philippines

Bryan Toledano

Pasig, Philippines

Keuffel Dangazo

Cebu, Philippines

Tips and tricks to tackle complex bifurcation lesions (left main and non left main)

09 Oct 2021 – From AICT-AsiaPCR 2021

This session will be of great value to you if you are looking for effective ways to best manage complex bifurcation lesions! More specifically, watch it if you wish to rapidly develop a patient-specific understanding of bifurcation lesions and treatment optimisation with physiology and IVUS co-registration, to...

Tips and tricks to tackle

Pushing boundaries in tricuspid therapy - the TricValve solution

08 Oct 2021 – From AICT-AsiaPCR 2021

Discover in this session a new strategy for the treatment of tricuspid regurgitation that can be an excellent alternative option to conventional treatment by studying it in a real situation, on a concrete case.

Pushing boundaries in

Left main bifurcation with DK crush technique

09 Oct 2021 – From AICT-AsiaPCR 2021

Don't miss this session from AICT-AsiaPCR 2021 if you wish to understand how imaging can help in strategising the PCI procedure in a calcified vessel, or to be familiar with how to perform bifurcation PCI of left main and LAD/D1 with two-stent technique, among others!

Left main bifurcation
Didn’t find what you were looking for?